APA (7th ed.) Citation

Orla Cunningham, Martin Scott, Zhaohui Sunny Zhou, & William J.J. Finlay. (2021). Polyreactivity and polyspecificity in therapeutic antibody development: Risk factors for failure in preclinical and clinical development campaigns. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Orla Cunningham, Martin Scott, Zhaohui Sunny Zhou, and William J.J. Finlay. Polyreactivity and Polyspecificity in Therapeutic Antibody Development: Risk Factors for Failure in Preclinical and Clinical Development Campaigns. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Orla Cunningham, et al. Polyreactivity and Polyspecificity in Therapeutic Antibody Development: Risk Factors for Failure in Preclinical and Clinical Development Campaigns. Taylor & Francis Group, 2021.